Healthcare Outcomes Performance Company (HOPCo), the largest orthopedic value-based care organization in the United States, continues its digital health platform expansion with the acquisition of MyACTome.
As the only validated smartphone-based fall risk and frailty assessment platform, MyACTome leverages motion sensors within a smartphone to assess patient balance, walking dynamics and dynamic stability patterns to quantify patient biomechanical performance, frailty score and fall risk. Using the MyACTome digital solution, patient assessments are quickly performed in the clinic or at home without the need for external sensors or expensive equipment, with results available instantly to the care team through web-based dashboards. Hundreds of thousands of assessments have been performed with MyACTome.
HOPCo provides musculoskeletal value-based health outcomes management, health system service line management and practice management software solutions. This includes management and optimization of specialties such as orthopedics, spine, neurosurgery, hand, pain management, rehabilitation and neurology. It is partnered with practices in more than 30 states.
MyACTome is being integrated into HOPCo’s existing digital health offering. This allows for real-time patient care pathway customization, all tracked through a centralized data system and reported to the clinical team. Financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this acquisition represents the 259th eHealth transaction of 2023, including 21 in the remote patient monitoring specialty. eHealth has been the third most active sector of the year, behind Other Services, a catchall for a variety of other healthcare verticals, with 506 deals, and Physician Medical Groups, with 481 deals.
